Evidence map›Paper›PMID 28656506›Full record

ArticleGlycoconjugate journal2017

Comparing naturally occurring glycosylated forms of proline rich antibacterial peptide, Drosocin.

Deepti S Lele, Gagandeep Kaur, Menithalaxmi Thiruvikraman, Kanwal J Kaur

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Deepti S LeleNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Gagandeep KaurNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Menithalaxmi ThiruvikramanNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
Kanwal J KaurNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India. kanwal@nii.ac.in.

Funding

Science and Engineering Research Board (IN) SR/S1/OC-63/2012
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are key players of innate immunity. Amongst various classes of AMPs, proline rich AMPs from insects enjoy special attention with few members of this class bearing O-glycosylation as post-translational modification. Drosocin, a 19 amino acid glycosylated AMP is a member of proline rich class, synthesized in the haemolymph of Drosophila melanogaster upon bacterial challenge. We report herein the chemical synthesis of drosocin carrying disaccharide (β-Gal(1 → 3)α-GalNAc) and comparison of its structural and functional properties with another naturally occurring monoglycosylated form of drosocin i.e. α-GalNAc-drosocin as well as with non-glycosylated drosocin. The disaccharide containing drosocin exhibited lower potency compared to monoglycosylated drosocin against all the tested Gram negative bacteria, suggesting the role of the distal sugar or increase in the sugar chain length on the activity. Circular dichroism studies failed to demonstrate the differential effect of sugars on the overall peptide conformation. Haemolytic and cytotoxic properties of drosocin were not altered due to an increase in the sugar chain length. In addition, we have also evaluated the effect of differentially glycosylated drosocins on two pro-inflammatory cytokines secreted by murine macrophages or LPS stimulated macrophages. All the drosocin forms tested, neither could stimulate the secretion of TNF-α and IL-6 nor could modulate LPS-induced levels of TNF-α and IL-6 in murine macrophages. This study provides insights about naturally occurring two different glycosylated forms of drosocin.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SequenceAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesDisaccharidesDrosophila melanogasterErythrocytesEscherichia coliGlycopeptidesGlycosylationHemolysisInterleukin-6Klebsiella pneumoniaeLipopolysaccharidesMiceAnti-Bacterial AgentsAntimicrobial Cationic PeptidesDisaccharidesdrosocinGlycopeptidesInterleukin-6interleukin-6, mouseLipopolysaccharidesTumor Necrosis Factor-alphaAntimicrobial peptidesDrosocinImmunomodulationProline richT-antigen

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.